Physician profile
Candace C Moore
NPI 1659308583
$9,077.40
in general payments reported to CMS, 2019-2025
23 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.63 · 2020: $67.73 · 2021: $160 · 2022: $359 · 2023: $7,772 · 2024: $326 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,585 · Travel and Lodging: $2,646 · Food and Beverage: $1,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,584.99 |
| Travel and Lodging | $2,645.75 |
| Food and Beverage | $1,205.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,252.12 | 2020-2023 | Davinci Xi, Da Vinci Surgical System |
| Astellas Pharma US INC | $400.91 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $255.41 | 2019-2025 | |
| Pfizer INC. | $199.90 | 2021-2024 | |
| Exeltis, USA INC. | $138.26 | 2019-2025 | Slynd |
| Coopersurgical, INC. | $101.58 | 2022-2025 | Ally II Ups |
| Amgen INC. | $100.00 | 2022 | |
| Revvity, INC. | $75.60 | 2023 | |
| Millicent US INC | $73.11 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Bayer Healthcare Pharmaceuticals INC. | $58.57 | 2025 | |
| Dexcom, INC. | $54.51 | 2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $53.36 | 2022-2023 | Aptima |
| Sumitomo Pharma America, INC. | $48.44 | 2024 | Myfembree |
| Organon LLC | $46.28 | 2024-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $44.66 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $34.60 | 2021 | |
| Integra Lifesciences Corporation | $33.18 | 2022 | |
| Baxter Healthcare | $26.28 | 2019 | |
| Sanara Medtech INC. | $20.00 | 2020 | |
| Axonics, INC. | $19.36 | 2024 | Bulkamid |
| Therapeuticsmd, INC. | $14.89 | 2021 | |
| Abbott Laboratories | $14.20 | 2022 | |
| Avion Pharmaceuticals | $12.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.